Global Anthrax Vaccines Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Anthrax Vaccines Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Live Vaccines
  • 1.2.3 Cell free PA Vaccines
• 1.3 Market by Application
  • 1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Human Use
  • 1.3.3 Animal Use
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Anthrax Vaccines Sales Estimates and Forecasts 2017-2028
• 2.2 Global Anthrax Vaccines Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Anthrax Vaccines Sales by Region
  • 2.4.1 Global Anthrax Vaccines Sales by Region (2017-2022)
  • 2.4.2 Global Sales Anthrax Vaccines by Region (2023-2028)
• 2.5 Global Anthrax Vaccines Revenue by Region
  • 2.5.1 Global Anthrax Vaccines Revenue by Region (2017-2022)
  • 2.5.2 Global Anthrax Vaccines Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Anthrax Vaccines Sales by Manufacturers
  • 3.1.1 Global Top Anthrax Vaccines Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anthrax Vaccines in 2021
• 3.2 Global Anthrax Vaccines Revenue by Manufacturers
  • 3.2.1 Global Anthrax Vaccines Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2021
• 3.3 Global Anthrax Vaccines Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Anthrax Vaccines Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Anthrax Vaccines Sales by Type
  • 4.1.1 Global Anthrax Vaccines Historical Sales by Type (2017-2022)
  • 4.1.2 Global Anthrax Vaccines Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
• 4.2 Global Anthrax Vaccines Revenue by Type
  • 4.2.1 Global Anthrax Vaccines Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Anthrax Vaccines Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• 4.3 Global Anthrax Vaccines Price by Type
  • 4.3.1 Global Anthrax Vaccines Price by Type (2017-2022)
  • 4.3.2 Global Anthrax Vaccines Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Anthrax Vaccines Sales by Application
  • 5.1.1 Global Anthrax Vaccines Historical Sales by Application (2017-2022)
  • 5.1.2 Global Anthrax Vaccines Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
• 5.2 Global Anthrax Vaccines Revenue by Application
  • 5.2.1 Global Anthrax Vaccines Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Anthrax Vaccines Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• 5.3 Global Anthrax Vaccines Price by Application
  • 5.3.1 Global Anthrax Vaccines Price by Application (2017-2022)
  • 5.3.2 Global Anthrax Vaccines Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Anthrax Vaccines Market Size by Type
  • 6.1.1 North America Anthrax Vaccines Sales by Type (2017-2028)
  • 6.1.2 North America Anthrax Vaccines Revenue by Type (2017-2028)
• 6.2 North America Anthrax Vaccines Market Size by Application
  • 6.2.1 North America Anthrax Vaccines Sales by Application (2017-2028)
  • 6.2.2 North America Anthrax Vaccines Revenue by Application (2017-2028)
• 6.3 North America Anthrax Vaccines Market Size by Country
  • 6.3.1 North America Anthrax Vaccines Sales by Country (2017-2028)
  • 6.3.2 North America Anthrax Vaccines Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Anthrax Vaccines Market Size by Type
  • 7.1.1 Europe Anthrax Vaccines Sales by Type (2017-2028)
  • 7.1.2 Europe Anthrax Vaccines Revenue by Type (2017-2028)
• 7.2 Europe Anthrax Vaccines Market Size by Application
  • 7.2.1 Europe Anthrax Vaccines Sales by Application (2017-2028)
  • 7.2.2 Europe Anthrax Vaccines Revenue by Application (2017-2028)
• 7.3 Europe Anthrax Vaccines Market Size by Country
  • 7.3.1 Europe Anthrax Vaccines Sales by Country (2017-2028)
  • 7.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Anthrax Vaccines Market Size by Type
  • 8.1.1 Asia Pacific Anthrax Vaccines Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Anthrax Vaccines Revenue by Type (2017-2028)
• 8.2 Asia Pacific Anthrax Vaccines Market Size by Application
  • 8.2.1 Asia Pacific Anthrax Vaccines Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Anthrax Vaccines Revenue by Application (2017-2028)
• 8.3 Asia Pacific Anthrax Vaccines Market Size by Region
  • 8.3.1 Asia Pacific Anthrax Vaccines Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Anthrax Vaccines Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Anthrax Vaccines Market Size by Type
  • 9.1.1 Latin America Anthrax Vaccines Sales by Type (2017-2028)
  • 9.1.2 Latin America Anthrax Vaccines Revenue by Type (2017-2028)
• 9.2 Latin America Anthrax Vaccines Market Size by Application
  • 9.2.1 Latin America Anthrax Vaccines Sales by Application (2017-2028)
  • 9.2.2 Latin America Anthrax Vaccines Revenue by Application (2017-2028)
• 9.3 Latin America Anthrax Vaccines Market Size by Country
  • 9.3.1 Latin America Anthrax Vaccines Sales by Country (2017-2028)
  • 9.3.2 Latin America Anthrax Vaccines Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Anthrax Vaccines Market Size by Type
  • 10.1.1 Middle East and Africa Anthrax Vaccines Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Anthrax Vaccines Market Size by Application
  • 10.2.1 Middle East and Africa Anthrax Vaccines Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Anthrax Vaccines Market Size by Country
  • 10.3.1 Middle East and Africa Anthrax Vaccines Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Emergent BioSolutions
  • 11.1.1 Emergent BioSolutions Corporation Information
  • 11.1.2 Emergent BioSolutions Overview
  • 11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Emergent BioSolutions Recent Developments
• 11.2 Merial
  • 11.2.1 Merial Corporation Information
  • 11.2.2 Merial Overview
  • 11.2.3 Merial Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Merial Recent Developments
• 11.3 Merck
  • 11.3.1 Merck Corporation Information
  • 11.3.2 Merck Overview
  • 11.3.3 Merck Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Merck Recent Developments
• 11.4 Zoetis
  • 11.4.1 Zoetis Corporation Information
  • 11.4.2 Zoetis Overview
  • 11.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Zoetis Recent Developments
• 11.5 Bayer Sanidad Animal
  • 11.5.1 Bayer Sanidad Animal Corporation Information
  • 11.5.2 Bayer Sanidad Animal Overview
  • 11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Bayer Sanidad Animal Recent Developments
• 11.6 Colorado Serum
  • 11.6.1 Colorado Serum Corporation Information
  • 11.6.2 Colorado Serum Overview
  • 11.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Colorado Serum Recent Developments
• 11.7 PharmAthene
  • 11.7.1 PharmAthene Corporation Information
  • 11.7.2 PharmAthene Overview
  • 11.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 PharmAthene Recent Developments
• 11.8 Tiankang
  • 11.8.1 Tiankang Corporation Information
  • 11.8.2 Tiankang Overview
  • 11.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Tiankang Recent Developments
• 11.9 Biogenesis-Bago
  • 11.9.1 Biogenesis-Bago Corporation Information
  • 11.9.2 Biogenesis-Bago Overview
  • 11.9.3 Biogenesis-Bago Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Biogenesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Biogenesis-Bago Recent Developments
• 11.10 CAVAC
  • 11.10.1 CAVAC Corporation Information
  • 11.10.2 CAVAC Overview
  • 11.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.10.4 CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 CAVAC Recent Developments
• 11.11 Rosenbusch
  • 11.11.1 Rosenbusch Corporation Information
  • 11.11.2 Rosenbusch Overview
  • 11.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.11.4 Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Rosenbusch Recent Developments
• 11.12 Agrovet
  • 11.12.1 Agrovet Corporation Information
  • 11.12.2 Agrovet Overview
  • 11.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.12.4 Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Agrovet Recent Developments
• 11.13 Vecol
  • 11.13.1 Vecol Corporation Information
  • 11.13.2 Vecol Overview
  • 11.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.13.4 Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Vecol Recent Developments
• 11.14 CVCRI
  • 11.14.1 CVCRI Corporation Information
  • 11.14.2 CVCRI Overview
  • 11.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.14.4 CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.14.5 CVCRI Recent Developments
• 11.15 IVPM
  • 11.15.1 IVPM Corporation Information
  • 11.15.2 IVPM Overview
  • 11.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.15.4 IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.15.5 IVPM Recent Developments
• 11.16 Prondil
  • 11.16.1 Prondil Corporation Information
  • 11.16.2 Prondil Overview
  • 11.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.16.4 Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.16.5 Prondil Recent Developments
• 11.17 CDV
  • 11.17.1 CDV Corporation Information
  • 11.17.2 CDV Overview
  • 11.17.3 CDV Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.17.4 CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.17.5 CDV Recent Developments
• 11.18 Indian Immunologicals
  • 11.18.1 Indian Immunologicals Corporation Information
  • 11.18.2 Indian Immunologicals Overview
  • 11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.18.4 Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.18.5 Indian Immunologicals Recent Developments
• 11.19 Botswana Vaccine Institute
  • 11.19.1 Botswana Vaccine Institute Corporation Information
  • 11.19.2 Botswana Vaccine Institute Overview
  • 11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.19.4 Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.19.5 Botswana Vaccine Institute Recent Developments
• 11.20 Ceva Sante Animale
  • 11.20.1 Ceva Sante Animale Corporation Information
  • 11.20.2 Ceva Sante Animale Overview
  • 11.20.3 Ceva Sante Animale Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.20.4 Ceva Sante Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.20.5 Ceva Sante Animale Recent Developments
• 11.21 Intervac
  • 11.21.1 Intervac Corporation Information
  • 11.21.2 Intervac Overview
  • 11.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.21.4 Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.21.5 Intervac Recent Developments
• 11.22 JOVAC
  • 11.22.1 JOVAC Corporation Information
  • 11.22.2 JOVAC Overview
  • 11.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.22.4 JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.22.5 JOVAC Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Anthrax Vaccines Industry Chain Analysis
• 12.2 Anthrax Vaccines Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Anthrax Vaccines Production Mode & Process
• 12.4 Anthrax Vaccines Sales and Marketing
  • 12.4.1 Anthrax Vaccines Sales Channels
  • 12.4.2 Anthrax Vaccines Distributors
• 12.5 Anthrax Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Anthrax Vaccines Industry Trends
• 13.2 Anthrax Vaccines Market Drivers
• 13.3 Anthrax Vaccines Market Challenges
• 13.4 Anthrax Vaccines Market Restraints

14 Key Findings in The Global Anthrax Vaccines Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Live Vaccines
• Table 3. Major Manufacturers of Cell free PA Vaccines
• Table 4. Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
• Table 7. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)
• Table 8. Global Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
• Table 9. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)
• Table 10. Global Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Anthrax Vaccines Revenue Market Share by Region (2017-2022)
• Table 12. Global Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Anthrax Vaccines Revenue Market Share by Region (2023-2028)
• Table 14. Global Anthrax Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
• Table 15. Global Anthrax Vaccines Sales Share by Manufacturers (2017-2022)
• Table 16. Global Anthrax Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Anthrax Vaccines Revenue Share by Manufacturers (2017-2022)
• Table 18. Anthrax Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
• Table 19. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2021)
• Table 21. Anthrax Vaccines Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Anthrax Vaccines Product Offered
• Table 23. Date of Manufacturers Enter into Anthrax Vaccines Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
• Table 26. Global Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
• Table 27. Global Anthrax Vaccines Sales Share by Type (2017-2022)
• Table 28. Global Anthrax Vaccines Sales Share by Type (2023-2028)
• Table 29. Global Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 30. Global Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 31. Global Anthrax Vaccines Revenue Share by Type (2017-2022)
• Table 32. Global Anthrax Vaccines Revenue Share by Type (2023-2028)
• Table 33. Anthrax Vaccines Price by Type (2017-2022) & (USD/Dose)
• Table 34. Global Anthrax Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
• Table 35. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
• Table 36. Global Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
• Table 37. Global Anthrax Vaccines Sales Share by Application (2017-2022)
• Table 38. Global Anthrax Vaccines Sales Share by Application (2023-2028)
• Table 39. Global Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Anthrax Vaccines Revenue Share by Application (2017-2022)
• Table 42. Global Anthrax Vaccines Revenue Share by Application (2023-2028)
• Table 43. Anthrax Vaccines Price by Application (2017-2022) & (USD/Dose)
• Table 44. Global Anthrax Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
• Table 45. North America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
• Table 46. North America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
• Table 47. North America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 48. North America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 49. North America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
• Table 50. North America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
• Table 51. North America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
• Table 54. North America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
• Table 55. North America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
• Table 58. Europe Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
• Table 59. Europe Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 60. Europe Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 61. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
• Table 62. Europe Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
• Table 63. Europe Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
• Table 66. Europe Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
• Table 67. Europe Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
• Table 70. Asia Pacific Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
• Table 71. Asia Pacific Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
• Table 74. Asia Pacific Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
• Table 75. Asia Pacific Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
• Table 78. Asia Pacific Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
• Table 79. Asia Pacific Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
• Table 82. Latin America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
• Table 83. Latin America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 84. Latin America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 85. Latin America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
• Table 86. Latin America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
• Table 87. Latin America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
• Table 90. Latin America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
• Table 91. Latin America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
• Table 94. Middle East and Africa Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
• Table 95. Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
• Table 98. Middle East and Africa Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
• Table 99. Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
• Table 102. Middle East and Africa Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
• Table 103. Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Emergent BioSolutions Corporation Information
• Table 106. Emergent BioSolutions Description and Major Businesses
• Table 107. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 108. Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Emergent BioSolutions Recent Developments
• Table 110. Merial Corporation Information
• Table 111. Merial Description and Major Businesses
• Table 112. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 113. Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Merial Recent Developments
• Table 115. Merck Corporation Information
• Table 116. Merck Description and Major Businesses
• Table 117. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 118. Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. Merck Recent Developments
• Table 120. Zoetis Corporation Information
• Table 121. Zoetis Description and Major Businesses
• Table 122. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 123. Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 124. Zoetis Recent Developments
• Table 125. Bayer Sanidad Animal Corporation Information
• Table 126. Bayer Sanidad Animal Description and Major Businesses
• Table 127. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 128. Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 129. Bayer Sanidad Animal Recent Developments
• Table 130. Colorado Serum Corporation Information
• Table 131. Colorado Serum Description and Major Businesses
• Table 132. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 133. Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 134. Colorado Serum Recent Developments
• Table 135. PharmAthene Corporation Information
• Table 136. PharmAthene Description and Major Businesses
• Table 137. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 138. PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 139. PharmAthene Recent Developments
• Table 140. Tiankang Corporation Information
• Table 141. Tiankang Description and Major Businesses
• Table 142. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 143. Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 144. Tiankang Recent Developments
• Table 145. Biogenesis-Bago Corporation Information
• Table 146. Biogenesis-Bago Description and Major Businesses
• Table 147. Biogenesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 148. Biogenesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 149. Biogenesis-Bago Recent Developments
• Table 150. CAVAC Corporation Information
• Table 151. CAVAC Description and Major Businesses
• Table 152. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 153. CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 154. CAVAC Recent Developments
• Table 155. Rosenbusch Corporation Information
• Table 156. Rosenbusch Description and Major Businesses
• Table 157. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 158. Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 159. Rosenbusch Recent Developments
• Table 160. Agrovet Corporation Information
• Table 161. Agrovet Description and Major Businesses
• Table 162. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 163. Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 164. Agrovet Recent Developments
• Table 165. Vecol Corporation Information
• Table 166. Vecol Description and Major Businesses
• Table 167. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 168. Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 169. Vecol Recent Developments
• Table 170. CVCRI Corporation Information
• Table 171. CVCRI Description and Major Businesses
• Table 172. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 173. CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 174. CVCRI Recent Developments
• Table 175. IVPM Corporation Information
• Table 176. IVPM Description and Major Businesses
• Table 177. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 178. IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 179. IVPM Recent Developments
• Table 180. Prondil Corporation Information
• Table 181. Prondil Description and Major Businesses
• Table 182. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 183. Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 184. Prondil Recent Developments
• Table 185. CDV Corporation Information
• Table 186. CDV Description and Major Businesses
• Table 187. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 188. CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 189. CDV Recent Developments
• Table 190. Indian Immunologicals Corporation Information
• Table 191. Indian Immunologicals Description and Major Businesses
• Table 192. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 193. Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 194. Indian Immunologicals Recent Developments
• Table 195. Botswana Vaccine Institute Corporation Information
• Table 196. Botswana Vaccine Institute Description and Major Businesses
• Table 197. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 198. Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 199. Botswana Vaccine Institute Recent Developments
• Table 200. Ceva Sante Animale Corporation Information
• Table 201. Ceva Sante Animale Description and Major Businesses
• Table 202. Ceva Sante Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 203. Ceva Sante Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 204. Ceva Sante Animale Recent Developments
• Table 205. Intervac Corporation Information
• Table 206. Intervac Description and Major Businesses
• Table 207. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 208. Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 209. Intervac Recent Developments
• Table 210. JOVAC Corporation Information
• Table 211. JOVAC Description and Major Businesses
• Table 212. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
• Table 213. JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
• Table 214. JOVAC Recent Developments
• Table 215. Key Raw Materials Lists
• Table 216. Raw Materials Key Suppliers Lists
• Table 217. Anthrax Vaccines Distributors List
• Table 218. Anthrax Vaccines Customers List
• Table 219. Anthrax Vaccines Market Trends
• Table 220. Anthrax Vaccines Market Drivers
• Table 221. Anthrax Vaccines Market Challenges
• Table 222. Anthrax Vaccines Market Restraints
• Table 223. Research Programs/Design for This Report
• Table 224. Key Data Information from Secondary Sources
• Table 225. Key Data Information from Primary Sources

List of Figures

• Figure 1. Anthrax Vaccines Product Picture
• Figure 3. Global Anthrax Vaccines Market Share by Type in 2021 & 2028
• Figure 3. Live Vaccines Product Picture
• Figure 4. Cell free PA Vaccines Product Picture
• Figure 5. Global Anthrax Vaccines Market Share by Application in 2021 & 2028
• Figure 6. Human Use
• Figure 7. Animal Use
• Figure 8. Anthrax Vaccines Report Years Considered
• Figure 9. Global Anthrax Vaccines Sales 2017-2028 (M Doses)
• Figure 10. Global Anthrax Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 11. Global Anthrax Vaccines Revenue 2017-2028 (US$ Million)
• Figure 12. Global Anthrax Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 13. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)
• Figure 14. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)
• Figure 15. North America Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
• Figure 16. North America Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 17. Europe Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
• Figure 18. Europe Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 19. Asia-Pacific Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
• Figure 20. Asia-Pacific Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 21. Latin America Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
• Figure 22. Latin America Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 23. Middle East & Africa Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
• Figure 24. Middle East & Africa Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
• Figure 25. The Anthrax Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 26. The Top 5 and 10 Largest Manufacturers of Anthrax Vaccines in the World: Market Share by Anthrax Vaccines Revenue in 2021
• Figure 27. Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 28. Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
• Figure 29. Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• Figure 30. Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
• Figure 31. Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• Figure 32. North America Anthrax Vaccines Sales Market Share by Type (2017-2028)
• Figure 33. North America Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• Figure 34. North America Anthrax Vaccines Sales Market Share by Application (2017-2028)
• Figure 35. North America Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• Figure 36. North America Anthrax Vaccines Sales Share by Country (2017-2028)
• Figure 37. North America Anthrax Vaccines Revenue Share by Country (2017-2028)
• Figure 38. U.S. Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 39. Canada Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 40. Europe Anthrax Vaccines Sales Market Share by Type (2017-2028)
• Figure 41. Europe Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• Figure 42. Europe Anthrax Vaccines Sales Market Share by Application (2017-2028)
• Figure 43. Europe Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• Figure 44. Europe Anthrax Vaccines Sales Share by Country (2017-2028)
• Figure 45. Europe Anthrax Vaccines Revenue Share by Country (2017-2028)
• Figure 46. Germany Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 47. France Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 48. U.K. Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 49. Italy Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 50. Russia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 51. Asia Pacific Anthrax Vaccines Sales Market Share by Type (2017-2028)
• Figure 52. Asia Pacific Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• Figure 53. Asia Pacific Anthrax Vaccines Sales Market Share by Application (2017-2028)
• Figure 54. Asia Pacific Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Anthrax Vaccines Sales Share by Region (2017-2028)
• Figure 56. Asia Pacific Anthrax Vaccines Revenue Share by Region (2017-2028)
• Figure 57. China Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 58. Japan Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 59. South Korea Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 60. India Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 61. Australia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 62. China Taiwan Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 63. Indonesia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 64. Thailand Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 65. Malaysia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 66. Latin America Anthrax Vaccines Sales Market Share by Type (2017-2028)
• Figure 67. Latin America Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• Figure 68. Latin America Anthrax Vaccines Sales Market Share by Application (2017-2028)
• Figure 69. Latin America Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• Figure 70. Latin America Anthrax Vaccines Sales Share by Country (2017-2028)
• Figure 71. Latin America Anthrax Vaccines Revenue Share by Country (2017-2028)
• Figure 72. Mexico Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 73. Brazil Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 74. Argentina Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 75. Middle East and Africa Anthrax Vaccines Sales Market Share by Type (2017-2028)
• Figure 76. Middle East and Africa Anthrax Vaccines Revenue Market Share by Type (2017-2028)
• Figure 77. Middle East and Africa Anthrax Vaccines Sales Market Share by Application (2017-2028)
• Figure 78. Middle East and Africa Anthrax Vaccines Revenue Market Share by Application (2017-2028)
• Figure 79. Middle East and Africa Anthrax Vaccines Sales Share by Country (2017-2028)
• Figure 80. Middle East and Africa Anthrax Vaccines Revenue Share by Country (2017-2028)
• Figure 81. Turkey Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 82. Saudi Arabia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 83. UAE Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
• Figure 84. Anthrax Vaccines Value Chain
• Figure 85. Anthrax Vaccines Production Process
• Figure 86. Channels of Distribution
• Figure 87. Distributors Profiles
• Figure 88. Bottom-up and Top-down Approaches for This Report
• Figure 89. Data Triangulation
• Figure 90. Key Executives Interviewed